Nanomedicine

Nanomedicine 由 Future Medicine Ltd. 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Nanoparticle-Based Drug Delivery、Nanoplatforms for cancer theranostics、RNA Interference and Gene Delivery 等主题的论文，这 3 个主题约占 43.1%，主导子领域为 Biomedical Engineering。（根据 OpenAlex 主题统计与中科院分区数据生成）

Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era.

来源：LetPub

研究方向（LetPub）：医学-纳米科技

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

4.51LetPub · 2026-09-13

CiteScore 2026-06

6.5LetPub · 2026-09-13

SJR 2026-06

0.68LetPub · 2026-09-13

SNIP 2026-06

0.59LetPub · 2026-09-13

h-index

93LetPub · 2026-09-13

h-index

160OpenAlex · 2026-10-01

i10-index

2,419OpenAlex · 2026-10-01

两年平均被引

4.87OpenAlex · 2026-10-01

自引率

4.3%LetPub · 2026-09-13

Gold OA 文章占比

5.94%LetPub · 2026-09-13

发文规模

年文章数

178LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

平均6.0个月LetPub · 2026-09-13

平均录用比例（社区反馈）

25%LetPub · 2026-09-13

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

出版商

Future Medicine Ltd.

出版国家或地区

ENGLAND

出版语言

English

出版周期

Monthly

创刊年份

2006

ISSN

1743-5889

电子版 ISSN

1748-6963

官方链接

• 期刊主页 ↗LetPub
• 投稿系统 ↗LetPub